Other chromosome abnormalities, not elsewhere classified

Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 Q99
  • Cause of death: ICD-10 Q99

2 out of 7 registries used, show all original rules.

165

4. Check minimum number of events

None

165

5. Include endpoints

None

165

6. Filter based on genotype QC (FinnGen only)

151

Control definitions (FinnGen only)

Control exclude
Q17_CHROMOSOMAL_ABNORMALITI_NOT_ELSEW_CLASSIFIED

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q9
Name in latin
Aliae abnormitates chromosomales non alibi classificatae

Case counts by codes

FinnGen case counts by registry codes:

No upset plot: unknown.

No upset table: unknown.

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2451 1010 1439
Only index persons 1621 699 922
Unadjusted period prevalence (%)
Whole population 0.04 0.03 0.04
Only index persons 0.03 0.03 0.04
Median age at first event (years)
Whole population 8.59 10.07 7.51
Only index persons 15.21 17.61 13.39

-FinnGen-

Key figures

All Female Male
Number of individuals 151 89 62
Unadjusted period prevalence (%) 0.03 0.03 0.03
Median age at first event (years) 21.48 30.97 7.87

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
164
Matched controls
1640
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A98, ,
ICD-O-3
+∞
220.7
158
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
181.9
139
*
Q998, ,
ICD-10 Finland
Other specified chromosome abnormalities
+∞
146.8
118
*
SAA02, ,
ICD-O-3
+∞
136.1
111
*
J01DB01, ,
ATC
cefalexin; oral
+∞
131.6
108
*
WX110, ,
ICD-O-3
+∞
125.7
104
*
SAA01, ,
ICD-O-3
+∞
122.9
102
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
117.2
98
*
Z315, ,
ICD-10 Finland
Genetic counselling
+∞
117.2
98
*
J069, ,
ICD-O-3
+∞
113.0
95
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
103.4
88
*
SCA01, ,
ICD-O-3
+∞
103.4
88
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
102.0
87
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
98.0
84
*
K021, ,
ICD-O-3
+∞
96.7
83
*
ZXE00, ,
ICD-O-3
+∞
94.0
81
*
SAA03, ,
ICD-O-3
+∞
94.0
81
*
Z012, ,
ICD-O-3
+∞
86.2
75
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
85.0
74
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
82.4
72
*
ZXD10, ,
ICD-O-3
+∞
81.1
71
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
79.9
70
*
GD1AA, ,
ICD-O-3
+∞
79.9
70
*
WZC00, ,
ICD-O-3
+∞
78.6
69
*
SPAT1315, ,
ICD-O-3
+∞
76.1
67
*
SFA10, ,
ICD-O-3
+∞
73.6
65
*
SPAT1317, ,
ICD-O-3
+∞
72.4
64
*
E0000UV, ,
ATC
+∞
72.4
64
*
SFA20, ,
ICD-O-3
+∞
71.1
63
*
R4110, ,
ICD-O-3
+∞
71.1
63
*
ZXE10, ,
ICD-O-3
+∞
71.1
63
*
-1, ,
ICD-O-3
+∞
68.7
61
*
EB1SA, ,
ICD-O-3
+∞
68.7
61
*
Z3231, ,
ICD-O-3
+∞
68.7
61
*
WX404, ,
ICD-O-3
+∞
65.0
58
*
EB1AA, ,
ICD-O-3
+∞
65.0
58
*
Z001, ,
ICD-O-3
+∞
63.8
57
*
WX402, ,
ICD-O-3
+∞
62.6
56
*
Z2221, ,
ICD-O-3
+∞
62.6
56
*
EBA00, ,
ICD-O-3
+∞
60.2
54
*
WX408, ,
ICD-O-3
+∞
60.2
54
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
60.2
54
*
EB1HA, ,
ICD-O-3
+∞
59.0
53
*
J01DA01, ,
ATC
[U] cefalexin
+∞
59.0
53
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
56.6
51
*
Z3226, ,
ICD-O-3
+∞
55.4
50
*
KMAK, ,
ICD-O-3
+∞
55.4
50
*
R06AE07, ,
ATC
cetirizine; oral
+∞
54.2
49
*
ZXD05, ,
ICD-O-3
+∞
54.2
49
*
WYA05, ,
ICD-O-3
+∞
54.2
49
*
Z011, ,
ICD-10 Finland
Examination of ears and hearing
+∞
54.2
49
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
54.2
49
*
SPAT1263, ,
ICD-O-3
+∞
51.9
47
*
SDA02, ,
ICD-O-3
+∞
51.9
47
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
51.9
47
*
WX290, ,
ICD-O-3
+∞
51.9
47
*
R74, ,
ICD-O-3
+∞
50.7
46
*
WZB00, ,
ICD-O-3
+∞
50.7
46
*
R01AD09, ,
ATC
mometasone; nasal
+∞
50.7
46
*
R83, ,
ICD-O-3
+∞
49.5
45
*
SPAT1312, ,
ICD-O-3
+∞
49.5
45
*
M03BX02, ,
ATC
tizanidine; oral
+∞
48.4
44
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
48.4
44
*
R2130, ,
ICD-O-3
+∞
48.4
44
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
48.4
44
*
SDA01, ,
ICD-O-3
+∞
48.4
44
*
SAB03, ,
ICD-O-3
+∞
48.4
44
*
SCA02, ,
ICD-O-3
+∞
47.2
43
*
SFA30, ,
ICD-O-3
+∞
47.2
43
*
D82, ,
ICD-O-3
+∞
46.0
42
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
44.9
41
*
R06AX27, ,
ATC
desloratadine; oral
+∞
44.9
41
*
SAB01, ,
ICD-O-3
+∞
44.9
41
*
SPAT1325, ,
ICD-O-3
+∞
43.7
40
*
SDA03, ,
ICD-O-3
+∞
43.7
40
*
FM1EE, ,
ICD-O-3
+∞
43.7
40
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
43.7
40
*
R05, ,
ICD-O-3
+∞
43.7
40
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
43.7
40
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
43.7
40
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
42.6
39
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
42.6
39
*
XF400, ,
ICD-O-3
+∞
41.4
38
*
VALMI, ,
ICD-O-3
+∞
41.4
38
*
R5110, ,
ICD-O-3
+∞
41.4
38
*
SPAT1256, ,
ICD-O-3
+∞
40.3
37
*
TPH04, ,
ICD-O-3
+∞
40.3
37
*
OAA40, ,
ICD-O-3
+∞
40.3
37
*
SPAT1249, ,
ICD-O-3
+∞
40.3
37
*
Z0389, ,
ICD-10 Finland
Observation for other suspected diseases and conditions
+∞
40.3
37
*
LC2BE, ,
ICD-O-3
+∞
40.3
37
*
JN3AE, ,
ICD-O-3
+∞
40.3
37
*
A03, ,
ICD-O-3
+∞
39.1
36
*
SAD01, ,
ICD-O-3
+∞
39.1
36
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
39.1
36
*
D19, ,
ICD-O-3
+∞
39.1
36
*
SPAT1316, ,
ICD-O-3
+∞
39.1
36
*
R620, ,
ICD-10 Finland
Delayed milestone
+∞
39.1
36
*
S18, ,
ICD-O-3
+∞
39.1
36
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
39.1
36
*
SPAT1253, ,
ICD-O-3
+∞
38.0
35
*
Z2446, ,
ICD-O-3
+∞
38.0
35
*
F83, ,
ICD-10 Finland
Mixed specific developmental disorders
+∞
38.0
35
*
Z2445, ,
ICD-O-3
+∞
36.9
34
*
Z508, ,
ICD-10 Finland
Care involving use of other rehabilitation procedures
+∞
35.7
33
*
R03BA05, ,
ATC
fluticasone; inhalant
+∞
35.7
33
*
WX700, ,
ICD-O-3
+∞
35.7
33
*
WZA90, ,
ICD-O-3
+∞
35.7
33
*
WYA30, ,
ICD-O-3
+∞
35.7
33
*
SPAT1310, ,
ICD-O-3
+∞
34.6
32
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
34.6
32
*
SPAT1283, ,
ICD-O-3
+∞
34.6
32
*
XA800, ,
ICD-O-3
+∞
34.6
32
*
A97, ,
ICD-O-3
+∞
33.5
31
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
33.5
31
*
OAB43, ,
ICD-O-3
+∞
33.5
31
*
Q992, ,
ICD-10 Finland
Fragile X chromosome
+∞
33.5
31
*
SPAT1301, ,
ICD-O-3
+∞
33.5
31
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
33.5
31
*
D07AA02, ,
ATC
hydrocortisone; topical
+∞
33.5
31
*
H660, ,
ICD-10 Finland
Acute suppurative otitis media
+∞
33.5
31
*
K0364, ,
ICD-O-3
+∞
32.4
30
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
32.4
30
*
E000001, ,
ATC
+∞
32.4
30
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
32.4
30
*
111, ,
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
32.4
30
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
32.4
30
*
Z039, ,
ICD-10 Finland
Observation for suspected disease or condition, unspecified
+∞
31.2
29
*
K020, ,
ICD-O-3
+∞
31.2
29
*
R568, ,
ICD-10 Finland
Other and unspecified convulsions
+∞
31.2
29
*
L17, ,
ICD-O-3
+∞
30.1
28
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
30.1
28
*
AA1CG, ,
ICD-O-3
+∞
30.1
28
*
R4120, ,
ICD-O-3
+∞
30.1
28
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
30.1
28
*
Z871, ,
ICD-O-3
+∞
30.1
28
*
D07AC01, ,
ATC
betamethasone; topical
+∞
30.1
28
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
30.1
28
*
ZXA10, ,
ICD-O-3
+∞
30.1
28
*
W01, ,
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
+∞
30.1
28
*
AA1BG, ,
ICD-O-3
+∞
30.1
28
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
29.0
27
*
DCA20, ,
ICD-O-3
+∞
29.0
27
*
UJD10, ,
ICD-O-3
+∞
29.0
27
*
S01CA01, ,
ATC
dexamethasone and antiinfectives; ophthalmic
+∞
29.0
27
*
H660, ,
ICD-O-3
+∞
29.0
27
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
29.0
27
*
H669, ,
ICD-O-3
+∞
29.0
27
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
29.0
27
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
29.0
27
*
GD1UA, ,
ICD-O-3
+∞
29.0
27
*
R21, ,
ICD-O-3
+∞
29.0
27
*
SPAT1383, ,
ICD-O-3
+∞
27.9
26
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
27.9
26
*
N06AB10, ,
ATC
escitalopram; oral
+∞
27.9
26
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
27.9
26
*
K021, ,
ICD-10 Finland
Caries of dentine
+∞
27.9
26
*
Q998, ,
ICD-O-3
+∞
27.9
26
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
26.8
25
*
FM1AE, ,
ICD-O-3
+∞
26.8
25
*
N03AG01, ,
ATC
valproic acid; systemic, rectal
+∞
26.8
25
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
26.8
25
*
SDE02, ,
ICD-O-3
+∞
26.8
25
*
R1230, ,
ICD-O-3
+∞
26.8
25
*
Z3229, ,
ICD-O-3
+∞
26.8
25
*
Z035, ,
ICD-10 Finland
Observation for other suspected cardiovascular diseases
+∞
25.7
24
*
N05AH04, ,
ATC
quetiapine; oral
+∞
25.7
24
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
25.7
24
*
ZXA05, ,
ICD-O-3
+∞
25.7
24
*
R03DC03, ,
ATC
montelukast; oral
+∞
25.7
24
*
F790, ,
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
25.7
24
*
SPAT1384, ,
ICD-O-3
+∞
25.7
24
*
Z363, ,
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
+∞
25.7
24
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
25.7
24
*
R4190, ,
ICD-O-3
+∞
25.7
24
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
24.6
23
*
EMB30, ,
ICD-O-3
+∞
24.6
23
*
ZXE20, ,
ICD-O-3
+∞
24.6
23
*
ZXA00, ,
ICD-O-3
+∞
24.6
23
*
O800, ,
ICD-10 Finland
Spontaneous vertex delivery
+∞
24.6
23
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
24.6
23
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
24.6
23
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
24.6
23
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
23.5
22
*
M796, ,
ICD-O-3
+∞
23.5
22
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
23.5
22
*
WW200, ,
ICD-O-3
+∞
23.5
22
*
N05AX08, ,
ATC
risperidone; systemic
+∞
23.5
22
*
GD1PA, ,
ICD-O-3
+∞
22.4
21
*
A28, ,
ICD-O-3
+∞
22.4
21
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
22.4
21
*
XF600, ,
ICD-O-3
+∞
22.4
21
*
MA2AE, ,
ICD-O-3
+∞
22.4
21
*
R4130, ,
ICD-O-3
+∞
22.4
21
*
R065, ,
ICD-10 Finland
Mouth breathing
+∞
22.4
21
*
SPAT1153, ,
ICD-O-3
+∞
22.4
21
*
Z712, ,
ICD-O-3
+∞
22.4
21
*
ZXE11, ,
ICD-O-3
+∞
21.3
20
*
AA1AD, ,
ICD-O-3
+∞
21.3
20
*
SDA04, ,
ICD-O-3
+∞
21.3
20
*
N01, ,
ICD-O-3
+∞
21.3
20
*
L309, ,
ICD-O-3
+∞
21.3
20
*
SCE00, ,
ICD-O-3
+∞
21.3
20
*
H653, ,
ICD-10 Finland
Chronic mucoid otitis media
+∞
21.3
20
*
SPAT1262, ,
ICD-O-3
+∞
21.3
20
*
D07AC13, ,
ATC
mometasone; topical
+∞
21.3
20
*
UDH02, ,
ICD-O-3
+∞
21.3
20
*
A09, ,
ICD-O-3
+∞
21.3
20
*
N06BA04, ,
ATC
methylphenidate; oral
+∞
21.3
20
*
SPAT1223, ,
ICD-O-3
+∞
21.3
20
*
Z760, ,
ICD-O-3
+∞
21.3
20
*
LC2AE, ,
ICD-O-3
+∞
21.3
20
*
SPAT1382, ,
ICD-O-3
+∞
21.3
20
*
N05CF01, ,
ATC
zopiclone; oral
+∞
21.3
20
*
H01, ,
ICD-O-3
+∞
21.3
20
*
F82, ,
ICD-10 Finland
Specific developmental disorder of motor function
+∞
21.3
20
*
L12, ,
ICD-O-3
+∞
20.2
19
*
R104, ,
ICD-O-3
+∞
20.2
19
*
UDC00, ,
ICD-O-3
+∞
20.2
19
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
20.2
19
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
20.2
19
*
SPAT1381, ,
ICD-O-3
+∞
20.2
19
*
K0510, ,
ICD-O-3
+∞
20.2
19
*
Z004, ,
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
20.2
19
*
N05BA04, ,
ATC
oxazepam; oral
+∞
20.2
19
*
ZX120, ,
ICD-O-3
+∞
20.2
19
*
SPAT1324, ,
ICD-O-3
+∞
20.2
19
*
N02CC01, ,
ATC
sumatriptan; nasal, systemic, rectal
+∞
20.2
19
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
20.2
19
*
EBA05, ,
ICD-O-3
+∞
20.2
19
*
U072, ,
ICD-O-3
+∞
19.1
18
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
19.1
18
*
DFF00, ,
ICD-O-3
+∞
19.1
18
*
M02AA07, ,
ATC
piroxicam; topical
+∞
19.1
18
*
Z718, ,
ICD-O-3
+∞
19.1
18
*
WX882, ,
ICD-O-3
+∞
19.1
18
*
W78, ,
ICD-O-3
+∞
19.1
18
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
19.1
18
*
TPH07, ,
ICD-O-3
+∞
19.1
18
*
SXC05, ,
ICD-O-3
+∞
19.1
18
*
Z1388, ,
ICD-O-3
+∞
19.1
18
*
L03, ,
ICD-O-3
+∞
19.1
18
*
H13, ,
ICD-O-3
+∞
19.1
18
*
SPAT1216, ,
ICD-O-3
+∞
19.1
18
*
S29, ,
ICD-O-3
+∞
19.1
18
*
K0382, ,
ICD-O-3
+∞
19.1
18
*
R103, ,
ICD-10 Finland
Pain localized to other parts of lower abdomen
+∞
19.1
18
*
SAB02, ,
ICD-O-3
+∞
19.1
18
*
S060, ,
ICD-10 Finland
Concussion
+∞
18.0
17
*
SFC01, ,
ICD-O-3
+∞
18.0
17
*
F801, ,
ICD-10 Finland
Expressive language disorder
+∞
18.0
17
*
N03AX14, ,
ATC
levetiracetam; systemic
+∞
18.0
17
*
D11, ,
ICD-O-3
+∞
18.0
17
*
OAA41, ,
ICD-O-3
+∞
18.0
17
*
ZYC01, ,
ICD-O-3
+∞
18.0
17
*
EBA15, ,
ICD-O-3
+∞
18.0
17
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
18.0
17
*
P85, ,
ICD-O-3
+∞
18.0
17
*
ZY010, ,
ICD-O-3
+∞
18.0
17
*
F29, ,
ICD-O-3
+∞
18.0
17
*
UJF32, ,
ICD-O-3
+∞
18.0
17
*
D07BA04, ,
ATC
hydrocortisone and antiseptics; topical
+∞
18.0
17
*
N03AX09, ,
ATC
lamotrigine; oral
+∞
18.0
17
*
E000002, ,
ATC
+∞
18.0
17
*
ZXE13, ,
ICD-O-3
+∞
18.0
17
*
SBB10, ,
ICD-O-3
+∞
18.0
17
*
SPAT1197, ,
ICD-O-3
+∞
18.0
17
*
WX400, ,
ICD-O-3
+∞
18.0
17
*
R11, ,
ICD-10 Finland
Nausea and vomiting
+∞
18.0
17
*
H669, ,
ICD-10 Finland
Otitis media, unspecified
+∞
18.0
17
*
LX1AE, ,
ICD-O-3
+∞
18.0
17
*
R01AD58, ,
ATC
fluticasone, combinations; nasal
+∞
18.0
17
*
ZXD20, ,
ICD-O-3
+∞
18.0
17
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
18.0
17
*
R06AE09, ,
ATC
levocetirizine; oral
+∞
17.0
16
*
L01, ,
ICD-O-3
+∞
17.0
16
*
ZXE06, ,
ICD-O-3
+∞
17.0
16
*
SPAT1306, ,
ICD-O-3
+∞
17.0
16
*
ND2AA, ,
ICD-O-3
+∞
17.0
16
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
17.0
16
*
M545, ,
ICD-O-3
+∞
17.0
16
*
MA2HE, ,
ICD-O-3
+∞
17.0
16
*
H01AC01, ,
ATC
somatropin; parenteral
+∞
17.0
16
*
K020, ,
ICD-10 Finland
Caries limited to enamel
+∞
17.0
16
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
17.0
16
*
WX320, ,
ICD-O-3
+∞
17.0
16
*
J010, ,
ICD-O-3
+∞
17.0
16
*
R06AX22, ,
ATC
ebastine; oral
+∞
17.0
16
*
XLD00, ,
ICD-O-3
+∞
17.0
16
*
SPAT1385, ,
ICD-O-3
+∞
17.0
16
*
N05BA09, ,
ATC
clobazam; oral
+∞
17.0
16
*
J189, ,
ICD-O-3
+∞
17.0
16
*
M255, ,
ICD-O-3
+∞
17.0
16
*
O049, ,
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
+∞
15.9
15
*
WX002, ,
ICD-O-3
+∞
15.9
15
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
15.9
15
*
J450, ,
ICD-10 Finland
Predominantly allergic asthma
+∞
15.9
15
*
K045, ,
ICD-O-3
+∞
15.9
15
*
ZXE30, ,
ICD-O-3
+∞
15.9
15
*
S21, ,
ICD-O-3
+∞
15.9
15
*
MA1AE, ,
ICD-O-3
+∞
15.9
15
*
OAA65, ,
ICD-O-3
+∞
15.9
15
*
A04, ,
ICD-O-3
+∞
15.9
15
*
Z014, ,
ICD-10 Finland
Gynaecological examination (general)(routine)
+∞
15.9
15
*
N06AB04, ,
ATC
citalopram; systemic
+∞
15.9
15
*
MCA10, ,
ICD-O-3
+∞
15.9
15
*
H522, ,
ICD-10 Finland
Astigmatism
+∞
15.9
15
*
R1250, ,
ICD-O-3
+∞
15.9
15
*
SAA04, ,
ICD-O-3
+∞
15.9
15
*
FM2CE, ,
ICD-O-3
+∞
15.9
15
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
15.9
15
*
R298, ,
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
+∞
15.9
15
*
IAA01, ,
ICD-O-3
+∞
15.9
15
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
15.9
15
*
F510, ,
ICD-O-3
+∞
15.9
15
*
J459, ,
ICD-10 Finland
Asthma, unspecified
+∞
15.9
15
*
R5180, ,
ICD-10 Finland
Headache
+∞
15.9
15
*
K0366, ,
ICD-O-3
+∞
15.9
15
*
SPAT1389, ,
ICD-O-3
+∞
15.9
15
*
SPAT1196, ,
ICD-O-3
+∞
15.9
15
*
W19, ,
ICD-10 Finland
Unspecified fall
+∞
15.9
15
*
R03CC02, ,
ATC
salbutamol; systemic
+∞
15.9
15
*
WZC30, ,
ICD-O-3
+∞
15.9
15
*
SHB00, ,
ICD-O-3
+∞
15.9
15
*
GD1QA, ,
ICD-O-3
+∞
15.9
15
*
R509, ,
ICD-O-3
+∞
15.9
15
*
XQ800, ,
ICD-O-3
+∞
15.9
15
*
J451, ,
ICD-10 Finland
Nonallergic asthma
+∞
14.8
14
*
F900, ,
ICD-10 Finland
Disturbance of activity and attention
+∞
14.8
14
*
J01DA08, ,
ATC
[U] cefaclor
+∞
14.8
14
*
WZC20, ,
ICD-O-3
+∞
14.8
14
*
M255, ,
ICD-10 Finland
Pain in joint
+∞
14.8
14
*
SFA40, ,
ICD-O-3
+∞
14.8
14
*
G03DB01, ,
ATC
dydrogesterone; oral
+∞
14.8
14
*
S82, ,
ICD-O-3
+∞
14.8
14
*
F900, ,
ICD-O-3
+∞
14.8
14
*
182, ,
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
+∞
14.8
14
*
N03AX16, ,
ATC
[U] pregabalin
+∞
14.8
14
*
C03CA01, ,
ATC
furosemide; systemic
+∞
14.8
14
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
14.8
14
*
SGC00, ,
ICD-O-3
+∞
14.8
14
*
R03BA02, ,
ATC
budesonide; inhalant
+∞
14.8
14
*
C08CA01, ,
ATC
amlodipine; oral
+∞
14.8
14
*
N05CD08, ,
ATC
midazolam; nasal, systemic
+∞
14.8
14
*
AA5HE, ,
ICD-O-3
+∞
14.8
14
*
H109, ,
ICD-O-3
+∞
14.8
14
*
FM1DE, ,
ICD-O-3
+∞
14.8
14
*
EBA10, ,
ICD-O-3
+∞
14.8
14
*
K0364, ,
ICD-10 Finland
Dental calculus supragingival
+∞
14.8
14
*
U071, ,
ICD-O-3
+∞
14.8
14
*
IGY99, ,
ICD-O-3
+∞
14.8
14
*
SPAT1308, ,
ICD-O-3
+∞
14.8
14
*
OAA30, ,
ICD-O-3
+∞
14.8
14
*
B02AA02, ,
ATC
tranexamic acid; systemic
+∞
13.7
13
*
D07CC01, ,
ATC
betamethasone and antibiotics; topical
+∞
13.7
13
*
DFF20, ,
ICD-O-3
+∞
13.7
13
*
K0366, ,
ICD-10 Finland
Tooth plaque
+∞
13.7
13
*
Z048, ,
ICD-10 Finland
Examination and observation for other specified reasons
+∞
13.7
13
*
J2190, ,
ICD-10 Finland
Acute obstructive bronchitis in children
+∞
13.7
13
*
O244, ,
ICD-10 Finland
Diabetes mellitus arising in pregnancy
+∞
13.7
13
*
WX105, ,
ICD-O-3
+∞
13.7
13
*
A03FA01, ,
ATC
metoclopramide; systemic, rectal
+∞
13.7
13
*
SPAT1380, ,
ICD-O-3
+∞
13.7
13
*
F3210, ,
ICD-10 Finland
Moderate depressive episode without somatic syndrome
+∞
13.7
13
*
SPAT1192, ,
ICD-O-3
+∞
13.7
13
*
R01BA51, ,
ATC
phenylpropanolamine, combinations; oral
+∞
13.7
13
*
D01BA02, ,
ATC
terbinafine; oral
+∞
13.7
13
*
F790, ,
ICD-O-3
+∞
13.7
13
*
F809, ,
ICD-10 Finland
Developmental disorder of speech and language, unspecified
+∞
13.7
13
*
L200, ,
ICD-10 Finland
Besnier prurigo
+∞
13.7
13
*
R05, ,
ICD-10 Finland
Cough
+∞
13.7
13
*
P01, ,
ICD-O-3
+∞
13.7
13
*
SPAT1260, ,
ICD-O-3
+∞
13.7
13
*
A23, ,
ICD-O-3
+∞
13.7
13
*
D06, ,
ICD-O-3
+∞
13.7
13
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
13.7
13
*
SPAT1230, ,
ICD-O-3
+∞
13.7
13
*
K359, ,
ICD-10 Finland
Acute appendicitis, unspecified
+∞
13.7
13
*
N06AB03, ,
ATC
fluoxetine; oral
+∞
13.7
13
*
Z637, ,
ICD-10 Finland
Other stressful life events affecting family and household
+∞
13.7
13
*
H81, ,
ICD-O-3
+∞
13.7
13
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
13.7
13
*
N06AB06, ,
ATC
sertraline; oral
+∞
13.7
13
*
J01FA01, ,
ATC
erythromycin; systemic
+∞
13.7
13
*
L28, ,
ICD-O-3
+∞
13.7
13
*
X58, ,
ICD-10 Finland
Exposure to other specified factors
+∞
13.7
13
*
L08, ,
ICD-O-3
+∞
13.7
13
*
NK6MA, ,
ICD-O-3
+∞
13.7
13
*
K0365, ,
ICD-O-3
+∞
13.7
13
*
EB1VA, ,
ICD-O-3
+∞
13.7
13
*
Z358, ,
ICD-10 Finland
Supervision of other high-risk pregnancies
+∞
13.7
13
*
R1260, ,
ICD-O-3
+∞
13.7
13
*
C07AA05, ,
ATC
propranolol; systemic
+∞
13.7
13
*
XF404, ,
ICD-O-3
+∞
13.7
13
*
B349, ,
ICD-10 Finland
Viral infection, unspecified
+∞
13.7
13
*
SPAT1379, ,
ICD-O-3
+∞
13.7
13
*
F700, ,
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
+∞
13.7
13
*
R03BA01, ,
ATC
beclometasone; inhalant
+∞
13.7
13
*
M751, ,
ICD-O-3
+∞
13.7
13
*
J209, ,
ICD-O-3
+∞
13.7
13
*
ZXE04, ,
ICD-O-3
+∞
12.7
12
*
W17, ,
ICD-10 Finland
Other fall from one level to another
+∞
12.7
12
*
R1210, ,
ICD-O-3
+∞
12.7
12
*
A10BA02, ,
ATC
metformin; oral
+∞
12.7
12
*
S04, ,
ICD-O-3
+∞
12.7
12
*
R03AK06, ,
ATC
salmeterol and fluticasone; inhalant
+∞
12.7
12
*
N05CF02, ,
ATC
zolpidem; oral
+∞
12.7
12
*
WX602, ,
ICD-O-3
+∞
12.7
12
*
N06AX16, ,
ATC
venlafaxine; oral
+∞
12.7
12
*
R5180, ,
ICD-O-3
+∞
12.7
12
*
Z505, ,
ICD-O-3
+∞
12.7
12
*
SPAT1254, ,
ICD-O-3
+∞
12.7
12
*
NG1AA, ,
ICD-O-3
+∞
12.7
12
*
MA2DE, ,
ICD-O-3
+∞
12.7
12
*
J209, ,
ICD-10 Finland
Acute bronchitis, unspecified
+∞
12.7
12
*
SFA00, ,
ICD-O-3
+∞
12.7
12
*
R2110, ,
ICD-O-3
+∞
12.7
12
*
G409, ,
ICD-10 Finland
Epilepsy, unspecified
+∞
12.7
12
*
SPAT1016, ,
ICD-O-3
+∞
12.7
12
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
12.7
12
*
Z392, ,
ICD-O-3
+∞
12.7
12
*
H100, ,
ICD-O-3
+∞
12.7
12
*
L15, ,
ICD-O-3
+∞
12.7
12
*
M01AX17, ,
ATC
nimesulide; oral
+∞
12.7
12
*
W11, ,
ICD-O-3
+∞
12.7
12
*
ZXE05, ,
ICD-O-3
+∞
12.7
12
*
R53, ,
ICD-10 Finland
Malaise and fatigue
+∞
12.7
12
*
H02AB07, ,
ATC
prednisone; oral
+∞
12.7
12
*
K5909, ,
ICD-10 Finland
Constipation, unspecified
+∞
12.7
12
*
I10, ,
ICD-O-3
+∞
12.7
12
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
12.7
12
*
SGA01, ,
ICD-O-3
+∞
12.7
12
*
J3010, ,
ICD-10 Finland
Allergic rhinitis due to pollen
+∞
12.7
12
*
Q999, ,
ICD-10 Finland
Chromosomal abnormality, unspecified
+∞
12.7
12
*
NH3AA, ,
ICD-O-3
+∞
12.7
12
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
12.7
12
*
J01AA07, ,
ATC
tetracycline; systemic
+∞
12.7
12
*
SPAT1386, ,
ICD-O-3
+∞
12.7
12
*
S934, ,
ICD-O-3
+∞
12.7
12
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
12.7
12
*
C09CA06, ,
ATC
candesartan; oral
+∞
12.7
12
*
Z015, ,
ICD-10 Finland
Diagnostic skin and sensitization tests
+∞
12.7
12
*
G404, ,
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
+∞
12.7
12
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
12.7
12
*
R01AD01, ,
ATC
beclometasone; nasal
+∞
12.7
12
*
WX704, ,
ICD-O-3
+∞
12.7
12
*
Z712, ,
ICD-10 Finland
Person consulting for explanation of investigation findings
+∞
12.7
12
*
Z018, ,
ICD-O-3
+∞
12.7
12
*
D07BB04, ,
ATC
hydrocortisone butyrate and antiseptics; topical
+∞
12.7
12
*
H920, ,
ICD-O-3
+∞
11.6
11
*
N300, ,
ICD-O-3
+∞
11.6
11
*
OAA67, ,
ICD-O-3
+∞
11.6
11
*
K0510, ,
ICD-10 Finland
Gingivitis (chronic) NOS
+∞
11.6
11
*
KH1AE, ,
ICD-O-3
+∞
11.6
11
*
SCA03, ,
ICD-O-3
+∞
11.6
11
*
N03AE01, ,
ATC
clonazepam; systemic
+∞
11.6
11
*
E000007, ,
ATC
+∞
11.6
11
*
N30, ,
ICD-O-3
+∞
11.6
11
*
D10, ,
ICD-O-3
+∞
11.6
11
*
U071, ,
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
+∞
11.6
11
*
R103, ,
ICD-O-3
+∞
11.6
11
*
J352, ,
ICD-10 Finland
Hypertrophy of adenoids
+∞
11.6
11
*
W22, ,
ICD-10 Finland
Striking against or struck by other object(s)
+∞
11.6
11
*
OAB48, ,
ICD-O-3
+∞
11.6
11
*
R1410, ,
ICD-O-3
+∞
11.6
11
*
W12, ,
ICD-O-3
+∞
11.6
11
*
ZY020, ,
ICD-O-3
+∞
11.6
11
*
G430, ,
ICD-10 Finland
Migraine without aura [common migraine]
+∞
11.6
11
*
P06, ,
ICD-O-3
+∞
11.6
11
*
N05AH03, ,
ATC
olanzapine; systemic
+∞
11.6
11
*
N979, ,
ICD-10 Finland
Female infertility, unspecified
+∞
11.6
11
*
R1100, ,
ICD-O-3
+∞
11.6
11
*
SPAT1362, ,
ICD-O-3
+∞
11.6
11
*
L02, ,
ICD-O-3
+∞
11.6
11
*
G02BA03, ,
ATC
plastic IUD with progestogen
+∞
11.6
11
*
SPAT1303, ,
ICD-O-3
+∞
11.6
11
*
L29, ,
ICD-O-3
+∞
11.6
11
*
SPAT1033, ,
ICD-O-3
+∞
11.6
11
*
SPAT1281, ,
ICD-O-3
+∞
11.6
11
*
Z713, ,
ICD-10 Finland
Dietary counselling and surveillance
+∞
11.6
11
*
NH1AA, ,
ICD-O-3
+∞
11.6
11
*
D02AX, ,
ATC
Other emollients and protectives
+∞
11.6
11
*
R42, ,
ICD-10 Finland
Dizziness and giddiness
+∞
11.6
11
*
WX722, ,
ICD-O-3
+∞
11.6
11
*
M01AG02, ,
ATC
tolfenamic acid; oral, rectal
+∞
11.6
11
*
EB1MA, ,
ICD-O-3
+∞
11.6
11
*
SPAT1240, ,
ICD-O-3
+∞
11.6
11
*
ZXD30, ,
ICD-O-3
+∞
11.6
11
*
TLC00, ,
ICD-O-3
+∞
11.6
11
*
R53, ,
ICD-O-3
+∞
11.6
11
*
D07AB08, ,
ATC
desonide; topical
+∞
11.6
11
*
SPAT1250, ,
ICD-O-3
+∞
11.6
11
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
11.6
11
*
SGA02, ,
ICD-O-3
+∞
11.6
11
*
WX892, ,
ICD-O-3
+∞
11.6
11
*
Z011, ,
ICD-O-3
+∞
11.6
11
*
C09CA01, ,
ATC
losartan; oral
+∞
11.6
11
*
D07CA01, ,
ATC
hydrocortisone and antibiotics; topical
+∞
10.5
10
*
R5599, ,
ICD-O-3
+∞
10.5
10
*
J351, ,
ICD-10 Finland
Hypertrophy of tonsils
+∞
10.5
10
*
Z301, ,
ICD-O-3
+∞
10.5
10
*
Z033, ,
ICD-10 Finland
Observation for suspected nervous system disorder
+∞
10.5
10
*
E039, ,
ICD-10 Finland
Hypothyroidism, unspecified
+∞
10.5
10
*
EMB10, ,
ICD-O-3
+∞
10.5
10
*
CK2X4, ,
ICD-O-3
+∞
10.5
10
*
C10AA01, ,
ATC
simvastatin; oral
+∞
10.5
10
*
UKC02, ,
ICD-O-3
+∞
10.5
10
*
L309, ,
ICD-10 Finland
Dermatitis, unspecified
+∞
10.5
10
*
SPAT1363, ,
ICD-O-3
+∞
10.5
10
*
O470, ,
ICD-10 Finland
False labour before 37 completed weeks of gestation
+∞
10.5
10
*
A06AD11, ,
ATC
lactulose; oral
+∞
10.5
10
*
M545, ,
ICD-10 Finland
Low back pain
+∞
10.5
10
*
J20, ,
ICD-O-3
+∞
10.5
10
*
TPH15, ,
ICD-O-3
+∞
10.5
10
*
Z349, ,
ICD-10 Finland
Supervision of normal pregnancy, unspecified
+∞
10.5
10
*
R03AC03, ,
ATC
terbutaline; inhalant
+∞
10.5
10
*
Z360, ,
ICD-10 Finland
Antenatal screening for chromosomal anomalies
+∞
10.5
10
*
J010, ,
ICD-10 Finland
Acute maxillary sinusitis
+∞
10.5
10
*
D06AX01, ,
ATC
fusidic acid; topical
+∞
10.5
10
*
Z039, ,
ICD-O-3
+∞
10.5
10
*
101, ,
Kela drug reimbursment
Anterior pituitary hypofunction
+∞
10.5
10
*
SGC10, ,
ICD-O-3
+∞
10.5
10
*
N05BA01, ,
ATC
diazepam; systemic, rectal
+∞
10.5
10
*
Z340, ,
ICD-10 Finland
Supervision of normal first pregnancy
+∞
10.5
10
*
PH2AE, ,
ICD-O-3
+∞
10.5
10
*
ZXE15, ,
ICD-O-3
+∞
10.5
10
*
Z321, ,
ICD-10 Finland
Pregnancy confirmed
+∞
10.5
10
*
A05, ,
ICD-O-3
+∞
10.5
10
*
SDE03, ,
ICD-O-3
+∞
10.5
10
*
183, ,
Kela drug reimbursment
Lamotrigin and topiramate
+∞
10.5
10
*
N10, ,
ICD-10 Finland
Acute tubulo-interstitial nephritis
+∞
10.5
10
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
10.5
10
*
IBZ01, ,
ICD-O-3
+∞
10.5
10
*
SCF02, ,
ICD-O-3
+∞
10.5
10
*
J040, ,
ICD-10 Finland
Acute laryngitis
+∞
10.5
10
*
N03AF02, ,
ATC
oxcarbazepine; oral
+∞
10.5
10
*
R06AX13, ,
ATC
loratadine; oral
+∞
10.5
10
*
L200, ,
ICD-O-3
+∞
10.5
10
*
S0251, ,
ICD-O-3
+∞
10.5
10
*
SPAT1156, ,
ICD-O-3
+∞
10.5
10
*
H66, ,
ICD-O-3
+∞
10.5
10
*
L04AX03, ,
ATC
methotrexate; systemic
+∞
10.5
10
*
H651, ,
ICD-10 Finland
Other acute nonsuppurative otitis media
+∞
10.5
10
*
J05AB11, ,
ATC
valaciclovir; oral
+∞
10.5
10
*
Z302, ,
ICD-10 Finland
Sterilization
+∞
10.5
10
*
SHA01, ,
ICD-O-3
+∞
10.5
10
*
Z876, ,
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
+∞
10.5
10
*
H5030, ,
ICD-10 Finland
Intermittent esotropy
+∞
10.5
10
*
OAB44, ,
ICD-O-3
+∞
10.5
10
*
R5140, ,
ICD-O-3
+∞
10.5
10
*
ULA02, ,
ICD-O-3
+∞
10.5
10
*
SPAT1193, ,
ICD-O-3
+∞
10.5
10
*
Z505, ,
ICD-10 Finland
Speech therapy
+∞
10.5
10
*
IGY02, ,
ICD-O-3
+∞
10.5
10
*
MAX99, ,
ICD-O-3
+∞
9.5
9
*
F03, ,
ICD-O-3
+∞
9.5
9
*
WZC05, ,
ICD-O-3
+∞
9.5
9
*
K0730, ,
ICD-O-3
+∞
9.5
9
*
F412, ,
ICD-O-3
+∞
9.5
9
*
R238, ,
ICD-O-3
+∞
9.5
9
*
C09AA02, ,
ATC
enalapril; systemic
+∞
9.5
9
*
N03AX12, ,
ATC
[U] gabapentin; oral
+∞
9.5
9
*
A02BA02, ,
ATC
ranitidine; systemic
+∞
9.5
9
*
H5031, ,
ICD-10 Finland
Intermittent exotropia
+∞
9.5
9
*
O9980, ,
ICD-10 Finland
The fear of childbirth
+∞
9.5
9
*
TAB00, ,
ICD-O-3
+∞
9.5
9
*
Z012, ,
ICD-10 Finland
Dental examination
+∞
9.5
9
*
J159, ,
ICD-10 Finland
Bacterial pneumonia, unspecified
+∞
9.5
9
*
SPAT1190, ,
ICD-O-3
+∞
9.5
9
*
H02AB02, ,
ATC
dexamethasone; systemic
+∞
9.5
9
*
IBA04, ,
ICD-O-3
+∞
9.5
9
*
H10, ,
ICD-O-3
+∞
9.5
9
*
202, ,
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
+∞
9.5
9
*
Z348, ,
ICD-10 Finland
Supervision of other normal pregnancy
+∞
9.5
9
*
R060, ,
ICD-10 Finland
Dyspnoea
+∞
9.5
9
*
KC1EE, ,
ICD-O-3
+∞
9.5
9
*
N300, ,
ICD-10 Finland
Acute cystitis
+∞
9.5
9
*
Z251, ,
ICD-O-3
+∞
9.5
9
*
SGA04, ,
ICD-O-3
+∞
9.5
9
*
J01DA06, ,
ATC
[U] cefuroxime
+∞
9.5
9
*
LCA06, ,
ICD-O-3
+∞
9.5
9
*
SPAT1220, ,
ICD-O-3
+∞
9.5
9
*
R876, ,
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
+∞
9.5
9
*
IGP01, ,
ICD-O-3
+∞
9.5
9
*
JN3AD, ,
ICD-O-3
+∞
9.5
9
*
MA2JE, ,
ICD-O-3
+∞
9.5
9
*
ICB01, ,
ICD-O-3
+∞
9.5
9
*
Z258, ,
ICD-O-3
+∞
9.5
9
*
F329, ,
ICD-10 Finland
Depressive episode, unspecified
+∞
9.5
9
*
K802, ,
ICD-10 Finland
Calculus of gallbladder without cholecystitis
+∞
9.5
9
*
C09AA05, ,
ATC
ramipril; oral
+∞
9.5
9
*
W00, ,
ICD-10 Finland
Fall on same level involving ice and snow
+∞
9.5
9
*
JN3BD, ,
ICD-O-3
+∞
9.5
9
*
R101, ,
ICD-O-3
+∞
9.5
9
*
E6601, ,
ICD-10 Finland
Obesity due to excess calories
+∞
9.5
9
*
L11, ,
ICD-O-3
+∞
9.5
9
*
D01, ,
ICD-O-3
+∞
9.5
9
*
N03AX11, ,
ATC
topiramate; oral
+∞
9.5
9
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
9.5
9
*
TQX10, ,
ICD-O-3
+∞
9.5
9
*
RD210, ,
ICD-O-3
+∞
9.5
9
*
A46, ,
ICD-10 Finland
Erysipelas
+∞
9.5
9
*
XG412, ,
ICD-O-3
+∞
9.5
9
*
SPAT1305, ,
ICD-O-3
+∞
9.5
9
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
9.5
9
*
K219, ,
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
+∞
9.5
9
*
Q992, ,
ICD-O-3
+∞
9.5
9
*
OAA32, ,
ICD-O-3
+∞
9.5
9
*
115, ,
Kela drug reimbursment
Breast cancer
+∞
9.5
9
*
L14, ,
ICD-O-3
+∞
8.4
8
*
C07AB02, ,
ATC
metoprolol; systemic
+∞
8.4
8
*
SGB30, ,
ICD-O-3
+∞
8.4
8
*
O8210, ,
ICD-10 Finland
Delivery by emergency caesarean section
+∞
8.4
8
*
K0730, ,
ICD-10 Finland
Spacing, abnormal of tooth or teeth
+∞
8.4
8
*
FXA00, ,
ICD-O-3
+∞
8.4
8
*
WVA20, ,
ICD-O-3
+∞
8.4
8
*
A499, ,
ICD-10 Finland
Bacterial infection, unspecified
+∞
8.4
8
*
Z208, ,
ICD-O-3
+∞
8.4
8
*
F791, ,
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
8.4
8
*
R062, ,
ICD-10 Finland
Wheezing
+∞
8.4
8
*
N05AX12, ,
ATC
aripiprazole; systemic
+∞
8.4
8
*
OAA22, ,
ICD-O-3
+∞
8.4
8
*
AA1DG, ,
ICD-O-3
+∞
8.4
8
*
R202, ,
ICD-10 Finland
Paraesthesia of skin
+∞
8.4
8
*
301, ,
Kela drug reimbursment
Growth hormone
+∞
8.4
8
*
A29, ,
ICD-O-3
+∞
8.4
8
*
R42, ,
ICD-O-3
+∞
8.4
8
*
Z380, ,
ICD-10 Finland
Singleton, born in hospital
+∞
8.4
8
*
SPAT1307, ,
ICD-O-3
+∞
8.4
8
*
SPAT1211, ,
ICD-O-3
+∞
8.4
8
*
ZX114, ,
ICD-O-3
+∞
8.4
8
*
WYA10, ,
ICD-O-3
+∞
8.4
8
*
FM1BE, ,
ICD-O-3
+∞
8.4
8
*
D06BX01, ,
ATC
metronidazole; topical
+∞
8.4
8
*
A04AA01, ,
ATC
ondansetron; systemic, rectal
+∞
8.4
8
*
H01CA02, ,
ATC
nafarelin; nasal
+∞
8.4
8
*
Z392, ,
ICD-10 Finland
Routine postpartum follow-up
+∞
8.4
8
*
J353, ,
ICD-10 Finland
Hypertrophy of tonsils with hypertrophy of adenoids
+∞
8.4
8
*
O021, ,
ICD-10 Finland
Missed abortion
+∞
8.4
8
*
SPAT1229, ,
ICD-O-3
+∞
8.4
8
*
K02, ,
ICD-O-3
+∞
8.4
8
*
H609, ,
ICD-O-3
+∞
8.4
8
*
RF120, ,
ICD-O-3
+∞
8.4
8
*
K0040, ,
ICD-10 Finland
Postnatal enamel hypoplasia
+∞
8.4
8
*
K041, ,
ICD-O-3
+∞
8.4
8
*
F799, ,
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
+∞
8.4
8
*
F700, ,
ICD-O-3
+∞
8.4
8
*
N951, ,
ICD-O-3
+∞
8.4
8
*
S610, ,
ICD-O-3
+∞
8.4
8
*
Z023, ,
ICD-O-3
+∞
8.4
8
*
Q2111, ,
ICD-10 Finland
Paten or persistent foramen ovale
+∞
8.4
8
*
RF210, ,
ICD-O-3
+∞
8.4
8
*
XKD00, ,
ICD-O-3
+∞
8.4
8
*
R060, ,
ICD-O-3
+∞
8.4
8
*
SPAT1360, ,
ICD-O-3
+∞
8.4
8
*
Z769, ,
ICD-10 Finland
Person encountering health services in unspecified circumstances
+∞
8.4
8
*
L04AX01, ,
ATC
azathioprine; systemic
+∞
8.4
8
*
SJD40, ,
ICD-O-3
+∞
8.4
8
*
N88, ,
ICD-O-3
+∞
8.4
8
*
SPAT1149, ,
ICD-O-3
+∞
8.4
8
*
Z350, ,
ICD-10 Finland
Supervision of pregnancy with history of infertility
+∞
8.4
8
*
R12, ,
ICD-O-3
+∞
8.4
8
*
SPAT1222, ,
ICD-O-3
+∞
8.4
8
*
FB1BD, ,
ICD-O-3
+∞
8.4
8
*
PJA12, ,
ICD-O-3
+∞
8.4
8
*
SPAT1148, ,
ICD-O-3
+∞
8.4
8
*
J210, ,
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
+∞
8.4
8
*
WX306, ,
ICD-O-3
+∞
8.4
8
*
N390, ,
ICD-O-3
+∞
8.4
8
*
IEP02, ,
ICD-O-3
+∞
8.4
8
*
SAD02, ,
ICD-O-3
+∞
8.4
8
*
T814, ,
ICD-10 Finland
Infection following a procedure, not elsewhere classified
+∞
8.4
8
*
R07, ,
ICD-O-3
+∞
8.4
8
*
XX4AW, ,
ICD-O-3
+∞
8.4
8
*
P22, ,
ICD-O-3
+∞
8.4
8
*
JKA21, ,
ICD-O-3
+∞
8.4
8
*
P02, ,
ICD-O-3
+∞
8.4
8
*
ICC04, ,
ICD-O-3
+∞
8.4
8
*
R628, ,
ICD-10 Finland
Other lack of expected normal physiological development
+∞
8.4
8
*
SBB00, ,
ICD-O-3
+∞
8.4
8
*
SPAT1297, ,
ICD-O-3
+∞
8.4
8
*
Z000, ,
ICD-10 Finland
General medical examination
+∞
8.4
8
*
P24, ,
ICD-O-3
+∞
8.4
8
*
N19, ,
ICD-O-3
+∞
8.4
8
*
WX307, ,
ICD-O-3
+∞
8.4
8
*
K0723, ,
ICD-O-3
+∞
8.4
8
*
J01DC02, ,
ATC
cefuroxime; systemic
+∞
8.4
8
*
IGV01, ,
ICD-O-3
+∞
8.4
8
*
SGB10, ,
ICD-O-3
+∞
8.4
8
*
WX702, ,
ICD-O-3
+∞
8.4
8
*
A99, ,
ICD-O-3
+∞
8.4
8
*
D10AX03, ,
ATC
azelaic acid; topical
+∞
8.4
8
*
OAA43, ,
ICD-O-3
+∞
8.4
8
*
K0880, ,
ICD-O-3
+∞
8.4
8
*
Q2110, ,
ICD-10 Finland
Persistent ostium secundum
+∞
7.3
7
*
A10AB05, ,
ATC
insulin aspart; parenteral
+∞
7.3
7
*
N17, ,
ICD-O-3
+∞
7.3
7
*
TDW99, ,
ICD-O-3
+∞
7.3
7
*
JEA01, ,
ICD-O-3
+∞
7.3
7
*
4451, ,
ICD-O-3
+∞
7.3
7
*
G04BD12, ,
ATC
mirabegron; oral
+∞
7.3
7
*
Z348, ,
ICD-O-3
+∞
7.3
7
*
Z370, ,
ICD-10 Finland
Single live birth
+∞
7.3
7
*
JEA00, ,
ICD-O-3
+∞
7.3
7
*
KF8AE, ,
ICD-O-3
+∞
7.3
7
*
SCF01, ,
ICD-O-3
+∞
7.3
7
*
C01CA24, ,
ATC
epinephrine; parenteral
+∞
7.3
7
*
JN3AA, ,
ICD-O-3
+∞
7.3
7
*
H02AB04, ,
ATC
methylprednisolone; systemic
+∞
7.3
7
*
CJE20, ,
ICD-O-3
+∞
7.3
7
*
G03GA06, ,
ATC
follitropin beta; parenteral
+∞
7.3
7
*
D225, ,
ICD-O-3
+∞
7.3
7
*
ICZ03, ,
ICD-O-3
+∞
7.3
7
*
G473, ,
ICD-O-3
+∞
7.3
7
*
Z321, ,
ICD-O-3
+∞
7.3
7
*
Z3232, ,
ICD-O-3
+∞
7.3
7
*
UGC12, ,
ICD-O-3
+∞
7.3
7
*
S934, ,
ICD-10 Finland
Sprain and strain of ankle
+∞
7.3
7
*
MA3AE, ,
ICD-O-3
+∞
7.3
7
*
HA1AE, ,
ICD-O-3
+∞
7.3
7
*
H520, ,
ICD-10 Finland
Hypermetropia
+∞
7.3
7
*
L02BG04, ,
ATC
letrozole; oral
+∞
7.3
7
*
Z000, ,
ICD-O-3
+∞
7.3
7
*
G43, ,
ICD-O-3
+∞
7.3
7
*
TDM10, ,
ICD-O-3
+∞
7.3
7
*
F710, ,
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
7.3
7
*
A10AC01, ,
ATC
insulin (human); parenteral
+∞
7.3
7
*
D07AD01, ,
ATC
clobetasol; topical
+∞
7.3
7
*
N80, ,
ICD-O-3
+∞
7.3
7
*
XCK10, ,
ICD-O-3
+∞
7.3
7
*
J01AA04, ,
ATC
lymecycline; systemic
+∞
7.3
7
*
FN1BC, ,
ICD-O-3
+∞
7.3
7
*
SPAT1224, ,
ICD-O-3
+∞
7.3
7
*
Q221, ,
ICD-10 Finland
Congenital pulmonary valve stenosis
+∞
7.3
7
*
WZC10, ,
ICD-O-3
+∞
7.3
7
*
SJX11, ,
ICD-O-3
+∞
7.3
7
*
LCH11, ,
ICD-O-3
+∞
7.3
7
*
E3435, ,
ICD-10 Finland
Abnormal growth retardation
+∞
7.3
7
*
F83, ,
ICD-O-3
+∞
7.3
7
*
H0410, ,
ICD-10 Finland
Dry eye syndrome
+∞
7.3
7
*
K040, ,
ICD-O-3
+∞
7.3
7
*
R29, ,
ICD-O-3
+∞
7.3
7
*
R229, ,
ICD-O-3
+∞
7.3
7
*
XX3DW, ,
ICD-O-3
+∞
7.3
7
*
S01GX08, ,
ATC
ketotifen; ophthalmic
+∞
7.3
7
*
M544, ,
ICD-O-3
+∞
7.3
7
*
Z509, ,
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
+∞
7.3
7
*
H501, ,
ICD-10 Finland
Divergent concomitant strabismus
+∞
7.3
7
*
F430, ,
ICD-O-3
+∞
7.3
7
*
ZXE03, ,
ICD-O-3
+∞
7.3
7
*
IGY01, ,
ICD-O-3
+∞
7.3
7
*
504, ,
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
+∞
7.3
7
*
N02AA05, ,
ATC
oxycodone; systemic
+∞
7.3
7
*
S02AA30, ,
ATC
antiinfectives, combinations; otic
+∞
7.3
7
*
E000006, ,
ATC
+∞
7.3
7
*
LDA20, ,
ICD-O-3
+∞
7.3
7
*
Q8788, ,
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
+∞
7.3
7
*
OAB95, ,
ICD-O-3
+∞
7.3
7
*
O814, ,
ICD-10 Finland
Vacuum extractor delivery
+∞
7.3
7
*
3046, ,
Kela drug reimbursment
+∞
7.3
7
*
WZA00, ,
ICD-O-3
+∞
7.3
7
*
O039, ,
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
+∞
7.3
7
*
SJC01, ,
ICD-O-3
+∞
7.3
7
*
H521, ,
ICD-10 Finland
Myopia
+∞
7.3
7
*
O351, ,
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
+∞
7.3
7
*
RS222, ,
ICD-O-3
+∞
7.3
7
*
RL140, ,
ICD-O-3
+∞
7.3
7
*
602, ,
Kela drug reimbursment
Children's severe malnutrition
+∞
7.3
7
*
G439, ,
ICD-O-3
+∞
7.3
7
*
F710, ,
ICD-O-3
+∞
7.3
7
*
W14, ,
ICD-O-3
+∞
7.3
7
*
XCW99, ,
ICD-O-3
+∞
7.3
7
*
KFH00, ,
ICD-O-3
+∞
7.3
7
*
SPAT1043, ,
ICD-O-3
+∞
7.3
7
*
-30, ,
ICD-O-3
+∞
7.3
7
*
OAB93, ,
ICD-O-3
+∞
7.3
7
*
R96, ,
ICD-O-3
+∞
7.3
7
*
IEY05, ,
ICD-O-3
+∞
7.3
7
*
J02, ,
ICD-O-3
+∞
7.3
7
*
A46, ,
ICD-O-3
+∞
7.3
7
*
O13, ,
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
+∞
7.3
7
*
NA1BG, ,
ICD-O-3
+∞
7.3
7
*
RL130, ,
ICD-O-3
+∞
7.3
7
*
XMA22, ,
ICD-O-3
+∞
7.3
7
*
R55, ,
ICD-10 Finland
Syncope and collapse
+∞
7.3
7
*
J039, ,
ICD-10 Finland
Acute tonsillitis, unspecified
+∞
7.3
7
*
G4022, ,
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
+∞
7.3
7
*
N390, ,
ICD-10 Finland
Urinary tract infection, site not specified
+∞
7.3
7
*
215, ,
Kela drug reimbursment
Diabetes, non-insulin-treated
+∞
7.3
7
*
Z003, ,
ICD-O-3
+∞
7.3
7
*
Z803, ,
ICD-10 Finland
Family history of malignant neoplasm of breast
+∞
7.3
7
*
186, ,
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
+∞
7.3
7
*
Z208, ,
ICD-10 Finland
Contact with and exposure to other communicable diseases
+∞
7.3
7
*
SJB10, ,
ICD-O-3
+∞
7.3
7
*
WYA20, ,
ICD-O-3
+∞
7.3
7
*
R560, ,
ICD-10 Finland
Febrile convulsions
+∞
7.3
7
*
112, ,
Kela drug reimbursment
Severe psychotic and other severe mental disorders
+∞
7.3
7
*
L09, ,
ICD-O-3
+∞
7.3
7
*
K210, ,
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
+∞
7.3
7
*
UJF30, ,
ICD-O-3
+∞
7.3
7
*
J459, ,
ICD-O-3
+∞
7.3
7
*
DCA10, ,
ICD-O-3
+∞
6.3
6
*
H609, ,
ICD-10 Finland
Otitis externa, unspecified
+∞
6.3
6
*
Z03, ,
ICD-O-3
+∞
6.3
6
*
E7801, ,
ICD-10 Finland
Pure hypercholesterolaemia
+∞
6.3
6
*
K0723, ,
ICD-10 Finland
Deep bite
+∞
6.3
6
*
CK2S4, ,
ICD-O-3
+∞
6.3
6
*
Z108, ,
ICD-O-3
+∞
6.3
6
*
N978, ,
ICD-10 Finland
Female infertility of other origin
+∞
6.3
6
*
OAA50, ,
ICD-O-3
+∞
6.3
6
*
H02, ,
ICD-O-3
+∞
6.3
6
*
Q532, ,
ICD-10 Finland
Undescended testicle, bilateral
+∞
6.3
6
*
R600, ,
ICD-O-3
+∞
6.3
6
*
R074, ,
ICD-O-3
+∞
6.3
6
*
M722, ,
ICD-O-3
+∞
6.3
6
*
F3210, ,
ICD-O-3
+∞
6.3
6
*
SPAT1058, ,
ICD-O-3
+∞
6.3
6
*
A10AE04, ,
ATC
insulin glargine; parenteral
+∞
6.3
6
*
OAB39, ,
ICD-O-3
+∞
6.3
6
*
R11, ,
ICD-O-3
+∞
6.3
6
*
OAB91, ,
ICD-O-3
+∞
6.3
6
*
1530, ,
Kela drug reimbursment
+∞
6.3
6
*
E109, ,
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
+∞
6.3
6
*
M01AH01, ,
ATC
celecoxib; oral
+∞
6.3
6
*
SJF01, ,
ICD-O-3
+∞
6.3
6
*
Z017, ,
ICD-O-3
+∞
6.3
6
*
R2120, ,
ICD-O-3
+∞
6.3
6
*
N06AX12, ,
ATC
bupropion; oral
+∞
6.3
6
*
G4059, ,
ICD-10 Finland
Other special epileptic syndromes
+∞
6.3
6
*
R31, ,
ICD-10 Finland
Unspecified haematuria
+∞
6.3
6
*
121, ,
Kela drug reimbursment
Severe hypofunction of sexual glands
+∞
6.3
6
*
G442, ,
ICD-O-3
+∞
6.3
6
*
H659, ,
ICD-10 Finland
Nonsuppurative otitis media, unspecified
+∞
6.3
6
*
TNX10, ,
ICD-O-3
+∞
6.3
6
*
R070, ,
ICD-O-3
+∞
6.3
6
*
X23, ,
ICD-O-3
+∞
6.3
6
*
R02, ,
ICD-O-3
+∞
6.3
6
*
N832, ,
ICD-10 Finland
Other and unspecified ovarian cysts
+∞
6.3
6
*
F419, ,
ICD-10 Finland
Anxiety disorder, unspecified
+∞
6.3
6
*
TNX33, ,
ICD-O-3
+∞
6.3
6
*
SJD10, ,
ICD-O-3
+∞
6.3
6
*
F813, ,
ICD-10 Finland
Mixed disorder of scholastic skills
+∞
6.3
6
*
W52, ,
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
+∞
6.3
6
*
J450, ,
ICD-O-3
+∞
6.3
6
*
OAB38, ,
ICD-O-3
+∞
6.3
6
*
SPAT1028, ,
ICD-O-3
+∞
6.3
6
*
H0410, ,
ICD-O-3
+∞
6.3
6
*
K0530, ,
ICD-O-3
+∞
6.3
6
*
Z027, ,
ICD-O-3
+∞
6.3
6
*
Z209, ,
ICD-10 Finland
Contact with and exposure to unspecified communicable disease
+∞
6.3
6
*
P29, ,
ICD-O-3
+∞
6.3
6
*
G03GA01, ,
ATC
chorionic gonadotrophin; parenteral
+∞
6.3
6
*
L04AA06, ,
ATC
mycophenolic acid; systemic
+∞
6.3
6
*
SPAT1212, ,
ICD-O-3
+∞
6.3
6
*
A08, ,
ICD-O-3
+∞
6.3
6
*
IEP03, ,
ICD-O-3
+∞
6.3
6
*
M531, ,
ICD-O-3
+∞
6.3
6
*
W85, ,
ICD-O-3
+∞
6.3
6
*
RT160, ,
ICD-O-3
+∞
6.3
6
*
Z352, ,
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
+∞
6.3
6
*
J040, ,
ICD-O-3
+∞
6.3
6
*
TKC20, ,
ICD-O-3
+∞
6.3
6
*
U01, ,
ICD-O-3
+∞
6.3
6
*
G4009, ,
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
+∞
6.3
6
*
NB1AA, ,
ICD-O-3
+∞
6.3
6
*
L02AE02, ,
ATC
leuprorelin; implant, parenteral
+∞
6.3
6
*
F818, ,
ICD-10 Finland
Other developmental disorders of scholastic skills
+∞
6.3
6
*
N47, ,
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
+∞
6.3
6
*
Z098, ,
ICD-10 Finland
Follow-up examination after other treatment for other conditions
+∞
6.3
6
*
MA2XE, ,
ICD-O-3
+∞
6.3
6
*
IBA01, ,
ICD-O-3
+∞
6.3
6
*
N03AX24, ,
ATC
cannabidiol; oral
+∞
6.3
6
*
MAE00, ,
ICD-O-3
+∞
6.3
6
*
G03HB01, ,
ATC
cyproterone and estrogen; oral
+∞
6.3
6
*
F88, ,
ICD-10 Finland
Other disorders of psychological development
+∞
6.3
6
*
C05AA08, ,
ATC
fluocortolone; rectal, topical
+∞
6.3
6
*
G439, ,
ICD-10 Finland
Migraine, unspecified
+∞
6.3
6
*
J01CF05, ,
ATC
flucloxacillin; systemic
+∞
6.3
6
*
Z024, ,
ICD-O-3
+∞
6.3
6
*
TDA90, ,
ICD-O-3
+∞
6.3
6
*
G04BD08, ,
ATC
solifenacin; oral
+∞
6.3
6
*
Q381, ,
ICD-10 Finland
Ankyloglossia
+∞
6.3
6
*
S01AA01, ,
ATC
chloramphenicol; ophthalmic
+∞
6.3
6
*
K590, ,
ICD-O-3
+∞
6.3
6
*
K0409, ,
ICD-O-3
+∞
6.3
6
*
-44, ,
ICD-O-3
+∞
6.3
6
*
RF420, ,
ICD-O-3
+∞
6.3
6
*
Z298, ,
ICD-O-3
+∞
6.3
6
*
P01BA02, ,
ATC
hydroxychloroquine; oral
+∞
6.3
6
*
H29, ,
ICD-O-3
+∞
6.3
6
*
331, ,
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
+∞
6.3
6
*
S06, ,
ICD-O-3
+∞
6.3
6
*
S16, ,
ICD-O-3
+∞
6.3
6
*
K30, ,
ICD-O-3
+∞
6.3
6
*
J01MA06, ,
ATC
norfloxacin; oral
+∞
6.3
6
*
F02, ,
ICD-O-3
+∞
6.3
6
*
SPAT1292, ,
ICD-O-3
+∞
6.3
6
*
HMAK, ,
ICD-O-3
+∞
6.3
6
*
WVA30, ,
ICD-O-3
+∞
6.3
6
*
S76, ,
ICD-O-3
+∞
6.3
6
*
D01AC02, ,
ATC
miconazole; topical
+∞
6.3
6
*
K80, ,
ICD-O-3
+∞
6.3
6
*
WX725, ,
ICD-O-3
+∞
6.3
6
*
Z988, ,
ICD-10 Finland
Other specified postsurgical states
+∞
6.3
6
*
G03GA05, ,
ATC
follitropin alfa; parenteral
+∞
6.3
6
*
OAB47, ,
ICD-O-3
+∞
6.3
6
*
D229, ,
ICD-O-3
+∞
6.3
6
*
GD1DD, ,
ICD-O-3
+∞
6.3
6
*
P76, ,
ICD-O-3
+∞
6.3
6
*
B01AC04, ,
ATC
clopidogrel; oral
+∞
6.3
6
*
K045, ,
ICD-10 Finland
Chronic apical periodontitis
+∞
6.3
6
*
K0522, ,
ICD-O-3
+∞
6.3
6
*
SJC50, ,
ICD-O-3
+∞
6.3
6
*
M791, ,
ICD-O-3
+∞
6.3
6
*
SJD00, ,
ICD-O-3
+∞
6.3
6
*
L16, ,
ICD-O-3
+∞
6.3
6
*
J020, ,
ICD-O-3
+∞
6.3
6
*
K591, ,
ICD-O-3
+∞
6.3
6
*
U02, ,
ICD-O-3
+∞
6.3
6
*
E0380, ,
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
+∞
6.3
6
*
S602, ,
ICD-O-3
+∞
6.3
6
*
SJB60, ,
ICD-O-3
+∞
6.3
6
*
F329, ,
ICD-O-3
+∞
6.3
6
*
Z468, ,
ICD-10 Finland
Fitting and adjustment of other specified devices
+∞
6.3
6
*
F791, ,
ICD-O-3
+∞
6.3
6
*
G431, ,
ICD-10 Finland
Migraine with aura [classical migraine]
+∞
6.3
6
*
K0713, ,
ICD-10 Finland
Retrognaty, mandibular
+∞
6.3
6
*
Z016, ,
ICD-O-3
+∞
6.3
6
*
U07, ,
ICD-O-3
+∞
6.3
6
*
OAA31, ,
ICD-O-3
+∞
6.3
6
*
A27, ,
ICD-O-3
+∞
6.3
6
*
T08, ,
ICD-O-3
+∞
6.3
6
*
IFA01, ,
ICD-O-3
+∞
6.3
6
*
M544, ,
ICD-10 Finland
Lumbago with sciatica
+∞
6.3
6
*
S800, ,
ICD-O-3
+∞
6.3
6
*
W84, ,
ICD-O-3
+∞
6.3
6
*
R620, ,
ICD-O-3
+∞
6.3
6
*
K0532, ,
ICD-O-3
+∞
6.3
6
*
G4029, ,
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
6.3
6
*
ZXD31, ,
ICD-O-3
+∞
6.3
6
*
EP1AE, ,
ICD-O-3
+∞
6.3
6
*
S22, ,
ICD-O-3
+∞
6.3
6
*
R629, ,
ICD-10 Finland
Lack of expected normal physiological development, unspecified
+∞
6.3
6
*
QBE10, ,
ICD-O-3
+∞
6.3
6
*
NA3AA, ,
ICD-O-3
+∞
6.3
6
*
DM1QA, ,
ICD-O-3
+∞
6.3
6
*
SJB00, ,
ICD-O-3
+∞
6.3
6
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
6.3
6
*
L700, ,
ICD-O-3
+∞
6.3
6
*
N481, ,
ICD-O-3
+∞
6.3
6
*
U072, ,
ICD-10 Finland
COVID-19, virus not identified
+∞
6.3
6
*
JAH01, ,
ICD-O-3
+∞
6.3
6
*
J06, ,
ICD-O-3
+∞
6.3
6
*
H103, ,
ICD-10 Finland
Acute conjunctivitis, unspecified
+∞
6.3
6
*
K0408, ,
ICD-O-3
+∞
6.3
6
*
H251, ,
ICD-10 Finland
Senile nuclear cataract
+∞
6.3
6
*
R13, ,
ICD-10 Finland
Dysphagia
+∞
6.3
6
*
K409, ,
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
+∞
6.3
6
*
F43, ,
ICD-O-3
+∞
6.3
6
*
G404, ,
ICD-O-3
+∞
6.3
6
*

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
16
21
8.31
7.59
1.1
1.0
—
—
—
0
0
98
687
2.06
4.80
13.9
13.2
1.22
1.23
mmol/l
0.72
93
638
26
107
2.70
4.58
2.7
1.9
13.01
17.58
iu/l
0.42
18
83
21
80
2.86
4.26
2.8
2.1
8.30
7.61
u/l
0.05
11
55
20
75
2.90
4.17
3.4
7.2
0.25
0.53
%
—
8
36
19
72
2.85
3.89
3.3
6.6
0.43
0.70
%
—
7
35
51
301
2.01
3.88
3.1
3.7
7.41
7.41
ph
—
5
48
45
255
2.05
3.82
2.6
2.3
160.24
454.38
u/l
1.05
45
250
18
68
2.85
3.70
3.4
7.6
0.00
0.00
%
—
6
29
102
770
1.86
3.57
9.5
8.7
6.01
6.02
mmol/l
0.02
96
713
103
794
1.80
3.22
7.3
10.3
—
—
—
0
0
6
9
6.87
2.89
3.2
2.2
16.25
26.66
umol/l
—
6
9
5
6
8.54
2.77
1.4
1.0
—
—
—
0
0
19
86
2.37
2.76
2.1
1.4
531.68
336.10
mu/l
0.86
19
78
115
946
1.72
2.57
9.9
12.5
3.49
3.67
e9/l
0.35
99
789
109
884
1.69
2.57
7.7
9.4
2.40
2.47
e9/l
0.17
98
754
106
856
1.67
2.52
7.7
9.4
0.04
0.04
e9/l
0.22
91
698
12
45
2.80
2.51
2.2
3.2
—
—
—
0
0
108
878
1.67
2.48
7.8
10.3
0.19
0.22
e9/l
0.75
96
741
106
858
1.67
2.47
7.7
9.4
0.60
0.58
e9/l
0.22
93
701
6
12
5.14
2.42
3.2
2.1
612.67
948.92
u/ml
—
6
12
44
285
1.74
2.40
3.3
4.4
—
—
—
0
0
23
120
2.07
2.40
1.5
1.7
—
—
—
0
0
51
347
1.68
2.33
4.0
8.1
1.04
1.18
inr
—
8
95
147
1320
2.10
2.24
12.7
12.1
54.52
58.64
umol/l
1.41
147
1320
79
605
1.59
2.23
2.6
2.6
—
—
—
0
0
31
186
1.82
2.17
1.8
1.8
—
—
—
0
0
0
57
0.00
2.10
0.0
1.1
—
—
—
0
0
8
26
3.18
2.04
4.1
4.0
—
—
—
0
0
46
318
1.62
1.95
5.9
11.1
1.31
1.36
mmol/l
0.54
46
300
17
86
2.09
1.93
4.4
2.5
876.52
6066.16
u/l
—
6
29
43
294
1.63
1.90
10.9
12.6
—
—
—
0
0
6
17
3.62
1.85
5.8
3.2
20.27
19.06
ug/l
—
6
17
34
228
1.62
1.61
3.0
7.3
30.04
31.53
s
0.83
34
228
149
1376
1.91
1.59
13.3
10.1
—
—
—
0
0
52
386
1.51
1.59
2.7
3.4
—
—
—
0
0
5
15
3.40
1.53
3.6
2.5
—
—
—
0
0
0
45
0.00
1.52
0.0
1.4
—
—
—
0
0
6
21
2.92
1.52
1.2
1.1
—
—
—
0
0
16
89
1.88
1.43
22.9
18.6
0.33
0.69
mmol/l
—
9
74
48
359
1.48
1.40
13.3
16.4
24.43
24.58
mmol/l
0.15
48
359
14
75
1.95
1.39
1.4
1.8
—
—
—
0
0
6
23
2.67
1.38
2.3
3.0
12.10
11.35
umol/l
—
6
23
43
317
1.48
1.34
4.1
10.5
0.68
0.99
mmol/l
0.34
30
236
6
24
2.56
1.31
1.8
3.5
—
—
—
0
0
9
44
2.11
1.29
1.7
4.6
65.00
63.75
%
—
9
44
9
44
2.11
1.29
1.7
4.6
17.22
10.36
%
—
9
44
20
125
1.68
1.24
1.0
1.3
116.00
130.04
iu/ml
—
5
49
6
126
0.46
1.23
1.3
1.3
—
—
—
0
0
6
26
2.36
1.20
1.2
1.6
0.32
0.25
nmol/l
—
6
20
59
473
1.39
1.16
2.6
4.4
103.63
40.60
e6/l
0.33
48
365
25
169
1.57
1.16
3.1
4.4
0.21
0.20
g/l
0.54
25
162
5
20
2.55
1.16
2.4
1.5
—
—
—
0
0
27
186
1.54
1.15
3.3
3.9
454.44
800.49
ng/l
0.63
18
128
36
264
1.47
1.15
2.3
4.6
1.76
1.17
mg/l
0.40
28
201
7
30
2.39
1.14
4.9
6.5
2.00
2.43
ug/l
—
7
30
8
41
2.00
1.10
6.3
3.1
20.64
33.42
u/ml
—
8
41
10
52
1.98
1.08
23.6
24.4
—
—
—
0
0
94
821
1.34
1.04
8.6
11.8
0.00
0.00
e9/l
0.66
77
614
5
22
2.31
1.04
3.6
1.7
110.60
143.86
ng/l
—
5
22
67
558
1.34
1.02
3.5
5.3
27.98
37.88
e6/l
0.24
49
379
7
35
2.04
1.01
1.0
1.1
—
—
—
0
0
23
158
1.53
1.00
2.8
1.9
—
—
—
0
0
5
23
2.21
0.98
4.6
4.2
54.40
53.96
%
—
5
23
40
309
1.39
0.97
2.0
2.4
—
—
—
0
0
54
440
1.34
0.94
3.1
4.3
0.33
0.33
e6/l
0.00
43
333
36
279
1.37
0.86
2.9
4.1
2.90
1.60
e6/l
0.39
22
167
6
31
1.97
0.85
1.2
1.3
—
—
—
0
0
24
173
1.45
0.85
3.8
4.0
8.40
8.60
g/l
0.10
24
165
27
201
1.41
0.81
1.8
3.3
12.72
14.05
umol/l
0.57
27
194
27
353
0.72
0.80
3.1
2.1
—
—
—
0
0
62
526
1.29
0.80
6.9
9.5
—
—
—
0
0
6
33
1.85
0.80
1.5
1.3
—
—
—
0
0
6
33
1.85
0.80
1.5
1.3
0.49
0.39
g/l
—
6
27
6
33
1.85
0.80
1.5
1.3
1.97
2.19
g/l
—
6
28
6
33
1.85
0.80
1.5
1.3
6.40
5.33
g/l
—
6
28
0
25
0.00
0.79
0.0
4.1
—
2.28
—
0
11
37
292
1.34
0.79
3.9
10.2
22.81
23.32
mmol/l
0.65
37
292
0
26
0.00
0.79
0.0
1.0
—
—
—
0
0
0
27
0.00
0.78
0.0
1.0
—
—
—
0
0
29
222
1.37
0.75
5.6
12.3
0.79
0.80
mmol/l
0.39
29
215
9
55
1.67
0.75
2.9
18.2
0.62
0.67
%
—
9
55
9
58
1.58
0.71
2.9
17.4
1.22
1.43
%
—
9
58
102
930
1.26
0.69
2.8
3.0
5.58
5.54
mmol/l
0.06
96
863
7
42
1.70
0.69
1.7
4.3
19.29
24.76
%
—
7
42
30
235
1.34
0.68
2.6
2.9
20.35
42.78
ng/l
0.54
17
109
24
182
1.37
0.66
1.8
3.4
2.42
2.59
g/l
1.17
24
177
7
44
1.62
0.66
4.4
2.0
—
—
—
0
0
5
29
1.75
0.64
1.2
3.2
—
—
—
0
0
61
532
1.23
0.60
1.7
1.7
1.74
1.55
g/l
0.49
36
261
86
941
0.82
0.59
4.1
3.3
1.40
1.46
mmol/l
0.78
81
890
36
297
1.27
0.57
14.6
11.9
—
—
—
0
0
87
947
0.83
0.55
4.1
3.5
2.80
2.74
mmol/l
0.29
81
897
6
99
0.59
0.53
1.7
2.3
5.33
4.20
e9/l
—
6
94
40
337
1.25
0.53
2.5
3.2
2.79
2.59
mg/l
0.25
35
300
9
63
1.45
0.53
1.7
5.7
1.24
1.23
mmol/l
—
9
56
16
118
1.39
0.52
1.0
1.4
491.20
518.35
pmol/l
—
10
106
14
101
1.42
0.51
1.6
1.3
—
—
—
0
0
7
45
1.58
0.49
1.7
4.6
36.20
34.65
%
—
7
45
94
868
1.19
0.49
3.5
4.5
—
—
—
0
0
39
333
1.22
0.46
16.7
12.0
—
7.41
—
0
9
15
112
1.37
0.46
1.5
1.5
—
—
—
0
0
7
50
1.42
0.45
2.6
5.8
—
—
—
0
0
7
50
1.42
0.45
1.7
4.5
20.00
16.92
%
—
7
50
51
449
1.20
0.45
2.8
4.2
—
—
—
0
0
26
313
0.80
0.44
1.8
1.8
—
—
—
0
0
5
31
1.63
0.43
5.4
5.9
—
—
—
0
0
5
31
1.63
0.43
1.0
4.6
27.00
27.87
umol/l
—
5
31
8
59
1.37
0.41
42.5
25.1
0.94
1.06
%
—
8
59
0
15
0.00
0.41
0.0
1.1
—
230.70
—
0
15
0
15
0.00
0.41
0.0
1.2
—
2.42
—
0
15
0
16
0.00
0.41
0.0
7.1
—
—
—
0
0
84
903
0.86
0.41
3.3
3.2
1.28
1.19
mmol/l
0.64
79
853
20
160
1.28
0.41
1.3
1.5
217.33
136.67
u/ml
0.35
20
147
8
60
1.35
0.41
42.5
24.7
0.54
0.73
%
—
8
60
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
59
532
1.17
0.39
1.5
1.7
4.83
1.87
u/ml
0.30
15
90
10
135
0.72
0.38
1.3
1.4
—
—
—
0
0
67
612
1.16
0.38
3.2
3.5
0.00
0.00
estimate
-0.00
11
109
33
379
0.84
0.36
2.1
2.1
—
—
—
0
0
16
127
1.29
0.35
1.3
1.2
—
—
—
0
0
10
133
0.74
0.35
1.2
1.9
—
—
—
0
0
66
606
1.15
0.34
4.5
5.3
0.00
0.00
estimate
—
10
109
23
193
1.22
0.33
6.7
6.6
1.84
1.48
%
0.81
23
186
143
1390
1.22
0.33
16.2
13.3
22.42
23.05
mg/l
0.09
114
1009
6
47
1.29
0.32
1.0
1.2
—
—
—
0
0
7
96
0.72
0.32
1.6
1.6
—
—
—
0
0
28
241
1.20
0.32
1.3
1.2
—
—
—
0
0
66
609
1.14
0.32
3.3
3.6
0.00
0.00
estimate
—
10
106
33
292
1.16
0.28
2.5
3.1
—
—
—
0
0
23
197
1.19
0.27
3.4
6.6
5.96
7.55
umol/l
0.31
17
163
5
74
0.67
0.26
1.2
1.4
—
—
—
0
0
20
170
1.20
0.26
3.4
3.4
276.87
107.22
mg/l
0.51
15
117
13
105
1.26
0.25
1.5
1.4
—
—
—
0
0
6
84
0.70
0.24
1.7
1.4
—
—
—
0
0
5
37
1.36
0.24
2.0
2.5
—
—
—
0
0
16
135
1.21
0.22
23.2
13.4
105.44
105.63
mmol/l
0.06
16
135
18
208
0.85
0.21
1.5
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
62.30
—
0
10
0
10
0.00
0.21
0.0
2.3
—
3.36
—
0
10
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
2.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
17
146
1.18
0.20
2.3
2.2
1.09
1.05
g/l
0.10
17
138
22
248
0.87
0.19
1.5
1.8
—
—
—
0
0
10
121
0.82
0.18
1.3
1.3
16.85
2.24
u/ml
—
10
99
6
77
0.77
0.16
1.2
1.1
—
—
—
0
0
6
79
0.75
0.16
1.7
1.9
—
—
—
0
0
8
95
0.83
0.14
2.4
3.5
—
—
—
0
0
11
128
0.85
0.14
1.7
2.1
—
—
—
0
0
32
297
1.10
0.13
3.7
3.5
0.00
0.00
estimate
-0.00
11
106
9
106
0.84
0.13
1.0
1.0
—
—
—
0
0
41
434
0.93
0.12
1.7
1.8
—
—
—
0
0
5
46
1.09
0.09
1.4
1.6
—
—
—
0
0
6
54
1.12
0.09
1.0
5.6
—
—
—
0
0
7
65
1.08
0.08
1.7
1.6
—
—
—
0
0
6
71
0.84
0.08
1.3
1.4
—
—
—
0
0
6
71
0.84
0.08
1.3
1.4
—
—
—
0
0
6
70
0.85
0.08
6.8
3.0
—
—
—
0
0
6
74
0.80
0.07
1.7
1.5
—
—
—
0
0
7
81
0.86
0.07
1.1
1.9
—
—
—
0
0
7
80
0.87
0.07
1.4
1.2
—
—
—
0
0
19
177
1.08
0.07
1.5
1.4
288.00
615.00
titre
—
5
32
33
316
1.06
0.06
1.6
1.7
94.12
96.42
pmol/l
0.10
15
168
15
140
1.08
0.04
8.5
5.1
87.40
65.98
e9/l
—
9
97
27
281
0.95
0.04
2.6
3.0
62.77
78.89
ug/g
0.37
22
229
10
108
0.92
0.03
1.5
1.4
—
—
—
0
0
36
352
1.03
0.02
3.6
3.4
—
—
—
0
0
40
407
0.98
0.01
1.6
1.8
—
—
—
0
0
10
94
1.07
0.01
1.4
1.5
—
—
—
0
0
17
176
0.96
0.00
1.6
1.2
6.30
6.29
u/ml
—
6
62
11
111
0.99
0.00
1.5
1.4
—
—
—
0
0
11
111
0.99
0.00
1.5
1.4
—
—
—
0
0
11
111
0.99
0.00
1.5
1.4
—
—
—
0
0
38
383
0.99
0.00
1.9
1.9
—
—
—
0
0
16
165
0.97
0.00
3.9
3.2
—
—
—
0
0
11
112
0.98
0.00
1.5
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
5
49
1.02
0.00
1.8
2.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
10.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
8.20
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
83.18
—
0
5
0
5
0.00
-0.00
0.0
15.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
224.82
—
0
5
6
61
0.98
-0.00
1.0
5.5
—
—
—
0
0
6
61
0.98
-0.00
2.2
2.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.3
—
1.06
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
1.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
9.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
7.66
—
0
5
0
7
0.00
-0.00
0.0
1.7
—
1.36
—
0
7
0
7
0.00
-0.00
0.0
3.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
38120.00
—
0
5
0
5
0.00
-0.00
0.0
1.2
—
268.00
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED and mortality.

Females

No data

Males

Parameter HR [95% CI] p-value
Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED 5.266 [3.59, 7.72] < 0.001
Birth year 0.986 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 81 out of 1126 males with Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED died.

Mortality risk

Mortality risk for people of age

years, who have Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED.

N-year risk Females Males
1 No data 1.035%
5 No data 6.0%
10 No data 13.624%
15 No data 24.885%
20 No data 40.393%

Relationships between endpoints

Index endpoint: Q17_OTHER_CHROMOSOME_ABNORMALITI_NOT_ELSEW_CLASSIFIED – Other chromosome abnormalities, not elsewhere classified

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data